The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding
Abstract
Significance: Dietary lipids are packaged into triglyceride-rich lipoprotein particles and delivered to many tissues via the bloodstream. A complex of lipoprotein lipase (LPL) and its endothelial cell receptor, GPIHBP1, hydrolyzes lipoprotein triglycerides, releasing fatty acids for uptake by surrounding cells. The efficiency of triglyceride hydrolysis is regulated by physiologic LPL inhibitors: ANGPTL-3, -4, and -8. We defined the binding site for ANGPTL4 on LPL and showed that ANGPTL4 induces allosteric changes in LPL that progress to irreversible unfolding and collapse of LPL’s catalytic site. The binding of GPIHBP1 to LPL augments LPL stability and renders LPL less susceptible to inactivation by ANGPTL4. Our studies provide crucial insights into molecular mechanisms that regulate intravascular triglyceride metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LPL bound to GPIHBP1 is largely protected from ANGPTL4.
“LPL bound to GPIHBP1 is largely protected from ANGPTL4 (51, 52, 60, 98).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [98]
ANGPTL4 can act on monomeric LPL and increases the inherent instability of LPL resulting in unfolding of LPL's catalytic domain.
“Indeed, a recent series of studies from the laboratory of Michael Ploug have shown that ANGPTL4 can act on monomeric LPL, and that ANGPTL4 increases the inherent instability of LPL resulting in the unfolding of LPL’s catalytic domain (52, 97, 98).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [98]
Several studies have indicated that ANGPTL4 catalytically inactivates LPL.
“Several studies have indicated that ANGPTL4 catalytically inactivates LPL (49, 51, 52, 97, 98).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
Graham, M. J., Lee, R. G., Brandt, T. A., Tai, L.-J., Fu, W., Peralta, R., Yu, R., Hurh, E., Paz, E., McEvoy, B. W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701329 · Cited by 573
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Dewey, F. E., Gusarova, V., O’Dushlaine, C., Gottesman, O., Trejos, J., Hunt, C., Van Hout, C. V., Habegger, L., Buckler, D., Lai, K.-M. V., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510926 · Cited by 497
ANGPTL3 deficiency and protection against coronary artery disease
Stitziel, N. O., Khera, A. V., Wang, X., Bierhals, A. J., Vourakis, A. C., Sperry, A. E., Natarajan, P., Klarin, D., Emdin, C. A., Zekavat, S. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.030 · Cited by 467
Chylomicronaemia–current diagnosis and future therapies
Brahm, A. J., & Hegele, R. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.26 · Cited by 356
Flagged first, then by citations
Research works printed but not linked: 45
- 10.1194/jlr.ILR120000735 · DOI
- 10.1016/j.cmet.2014.01.017 · DOI · Paper page
- 10.1016/j.cmet.2019.05.023 · DOI
- 10.1056/NEJMoa1611930 · DOI
- 10.1161/CIRCRESAHA.116.305085 · DOI
- 10.1016/j.jacl.2015.09.007 · DOI
- 10.1074/jbc.M114.558528 · DOI
- 10.1016/j.cgh.2020.08.016 · DOI
- 10.1038/ng.3561 · DOI
- 10.3390/ijms20112760 · DOI
- 10.1016/j.cmet.2010.04.016 · DOI · Paper page
- 10.1073/pnas.1806774115 · DOI
- 10.7554/eLife.12095 · DOI
- 10.7554/eLife.20958 · DOI · Paper page
- 10.1194/jlr.M900145-JLR200 · DOI · Paper page
- 10.1074/jbc.M114.623769 · DOI · Paper page
- 10.1194/jlr.ILR120000780 · DOI
- 10.1098/rsob.150272 · DOI
- 10.1194/jlr.M075689 · DOI · Paper page
- 10.1210/en.2016-1894 · DOI
- 10.1194/jlr.RA120000781 · DOI · Paper page
- 10.1194/jlr.M088807 · DOI · Paper page
- 10.1016/j.molmet.2020.101033 · DOI
- 10.1172/jci.insight.138777 · DOI · Paper page
- 10.1074/jbc.M113.497602 · DOI · Paper page
- 10.1074/jbc.RA118.005932 · DOI
- 10.1073/pnas.0604026103 · DOI · Paper page
- 10.1073/pnas.1920202117 · DOI · Paper page
- 10.1073/pnas.1900983116 · DOI · Paper page
- 10.1074/jbc.RA119.011079 · DOI
- 10.1074/jbc.M807899200 · DOI · Paper page
- 10.1073/pnas.1817984116 · DOI
- 10.1194/jlr.D119000388 · DOI
- 10.1021/acs.analchem.0c01828 · DOI
- 10.1038/s41592-019-0459-y · DOI
- 10.1146/annurev-biophys-062215-011121 · DOI
- 10.1039/C0CS00113A · DOI
- 10.1002/anie.201402796 · DOI
- 10.1194/jlr.M067363 · DOI · Paper page
- 10.1074/jbc.RA118.002426 · DOI · Paper page
- 10.1016/j.molmet.2017.06.014 · DOI · Paper page
- 10.1074/jbc.M111.303529 · DOI · Paper page
- 10.1016/0076-6879(91)97160-Z · DOI
- 10.1074/jbc.RA119.007847 · DOI
- 10.1007/s13361-013-0727-5 · DOI
Cited by
Sorted by citations
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Metadata
- Authors
- Leth-Espensen, K. Z., Kristensen, K. K., Kumari, A., Winther, A.-M. L., Young, S. G., Jørgensen, T. J. D., & Ploug, M.
- Affiliations
- Finsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark;
- Department of Medicine, University of California, Los Angeles, CA 90095;
- Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2021-03-15
- Volume
- 118
- Issue
- 12
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 48
- References
- 5
- Language
- en
- Funders
- HHS | NIH | National Heart, Lung, and Blood Institute (HL146358, HL087228, HL139725)
- Lundbeckfonden (R230-2016-2930)
- Novo Nordisk (NNF18OC0033864, NNF20OC0063444)
- The John and Birthe Meyer Foundation (0)
- The European Union’s Horizon 2020 research and innovation program (801481)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review